{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:34:03Z","timestamp":1791952443942,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1046812"],"award-info":[{"award-number":["1046812"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1098337"],"award-info":[{"award-number":["1098337"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1131932"],"award-info":[{"award-number":["1131932"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijid.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:57:42Z","timestamp":1547639862000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Oral eradication therapy for melioidosis: Important but not without risks"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-1673","authenticated-orcid":false,"given":"R.P.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-8837","authenticated-orcid":false,"given":"B.J.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijid.2019.01.019_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/520218","article-title":"A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis","volume":"29","author":"Chaowagul","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.019_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2008.78.208","article-title":"Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis","volume":"78","author":"Cheng","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"9919","key":"10.1016\/j.ijid.2019.01.019_bib0015","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(13)61951-0","article-title":"Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"383","author":"Chetchotisakd","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2019.01.019_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.01.019_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1086\/318116","article-title":"Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature","volume":"31","author":"Currie","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2019.01.019_bib0030","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","article-title":"The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20\u2009year Darwin prospective study","volume":"4","author":"Currie","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.01.019_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.ijid.2019.01.019_bib0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-3156.2004.01244.x","article-title":"Out of hospital treatment of patients with melioidosis using ceftazidime in 24\u2009h elastomeric infusors, via peripherally inserted central catheters","volume":"9","author":"Huffam","year":"2004","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.019_bib0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0924-8579(00)00334-4","article-title":"Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis","volume":"17","author":"Jenney","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.01.019_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.ijid.2019.01.019_bib0055","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3201\/eid1812.120638","article-title":"Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010","volume":"18","author":"Lipsitz","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.01.019_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003586","article-title":"Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm","volume":"9","author":"Pitman","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.ijid.2019.01.019_bib0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0035-9203(95)90104-3","article-title":"A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis","volume":"89","author":"Rajchanuvong","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.019_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/JCM.02239-13","article-title":"Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare","volume":"52","author":"Sarovich","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ijid.2019.01.019_bib0075","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2019.01.019_bib0080","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121930030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121930030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:40:50Z","timestamp":1565214050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121930030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"alternative-id":["S120197121930030X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.01.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral eradication therapy for melioidosis: Important but not without risks","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}